Activating mutations of FLT3 by internal tandem duplications or activating mutations of the FLT3 receptor are seen in a large percentage of AML patients associated with increased DNA DSBs, genome instability, and poor prognosis [124]. Here, FLT3 is linked to acute myeloid leukemia.